Company intelligence / Profile preview

LIVISTO

Germany

Ownership: Private
Employees: ~750
Development stage: Other

Overview

LIVISTO develops, manufactures, and markets a broad portfolio of pharmaceutical and nutritional products for the prevention and treatment of key animal health conditions across livestock and companion animal species. The company operates globally with commercialized products addressing parasitic diseases, mastitis, fertility management, dental care, cardiovascular support, among others. No clinical trial data as it focuses on veterinary medicines.

Therapeutic areas: CardiovascularEndocrinologyInfectious DiseasesOther
Modalities: Small moleculeBiologic (for veterinary use)Nutritional product (nutraceuticals)Vaccine (veterinary vaccines)Protein (where applicable in animal health products)
Industry: Veterinary

Beyond the preview

Go deeper on LIVISTO.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on LIVISTO.

Explore the full profile